Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
104.831,17
0,10%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 23andMe Holding Company (ME) 23andMe Holding Company (ME) Notizie

ME

23andMe (ME)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ME
DataOraFonteTitoloSimboloCompagnia
08/01/202513:30GlobeNewswire Inc.23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted TechnologyNASDAQ:ME23andMe Holding Company
21/11/202422:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
20/11/202413:30GlobeNewswire Inc.23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & InflammationNASDAQ:ME23andMe Holding Company
16/11/202403:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ME23andMe Holding Company
15/11/202422:48Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
13/11/202412:00Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ME23andMe Holding Company
12/11/202413:30GlobeNewswire Inc.23andMe Reports Second Quarter Fiscal Year 2025 Financial ResultsNASDAQ:ME23andMe Holding Company
11/11/202423:30GlobeNewswire Inc.23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the FutureNASDAQ:ME23andMe Holding Company
07/11/202423:54GlobeNewswire Inc.CORRECTION - 23andMe to Report Q2 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
07/11/202413:30GlobeNewswire Inc.23andMe to Report Q2 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
30/10/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
30/10/202422:00GlobeNewswire Inc.23andMe Regains Compliance With Nasdaq Listing RequirementsNASDAQ:ME23andMe Holding Company
29/10/202412:30GlobeNewswire Inc.23andMe Appoints Three New Independent Directors to BoardNASDAQ:ME23andMe Holding Company
17/10/202422:05GlobeNewswire Inc.23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the SouthNASDAQ:ME23andMe Holding Company
16/10/202414:15GlobeNewswire Inc.23andMe Announces Completion of 1-for-20 Reverse Stock SplitNASDAQ:ME23andMe Holding Company
11/10/202414:15GlobeNewswire Inc.23andMe Announces 1-for-20 Reverse Stock SplitNASDAQ:ME23andMe Holding Company
08/10/202413:00GlobeNewswire Inc.23andMe Announces Mathew Knowles as New Brand AmbassadorNASDAQ:ME23andMe Holding Company
25/09/202413:30GlobeNewswire Inc.23andMe Launches New Genetic Report on Likelihood of Frequent Emotional EatingNASDAQ:ME23andMe Holding Company
18/09/202412:13IH Market NewsMeta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates SpectaclesNASDAQ:ME23andMe Holding Company
17/09/202422:26GlobeNewswire Inc.Independent Directors of 23andMe Resign from BoardNASDAQ:ME23andMe Holding Company
15/09/202409:00GlobeNewswire Inc.23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 TrialNASDAQ:ME23andMe Holding Company
15/09/202409:00GlobeNewswire Inc.23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 StudyNASDAQ:ME23andMe Holding Company
12/09/202422:05GlobeNewswire Inc.One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All PopulationsNASDAQ:ME23andMe Holding Company
12/09/202412:02IH Market NewsNorfolk Southern CEO Fired, Ryanair Lowers Fare Forecast, 23andMe Considers Acquisition ProposalsNASDAQ:ME23andMe Holding Company
03/09/202413:30GlobeNewswire Inc.23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024NASDAQ:ME23andMe Holding Company
28/08/202413:30GlobeNewswire Inc.Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership ProgramNASDAQ:ME23andMe Holding Company
08/08/202422:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ME23andMe Holding Company
08/08/202422:05GlobeNewswire Inc.23andMe Reports First Quarter Fiscal 2025 Financial ResultsNASDAQ:ME23andMe Holding Company
05/08/202411:43IH Market NewsNvidia AI Chip Delays, Mars Eyes Kellanova Acquisition, Berkshire Hathaway’s Cash Surge to $277 BillionNASDAQ:ME23andMe Holding Company
02/08/202414:00GlobeNewswire Inc.23andMe Special Committee responds to CEO’s take-private proposalNASDAQ:ME23andMe Holding Company
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ME

La tua Cronologia

BIT
BMPS
Banca Monte Dei Paschi D...
BIT
UCG
Unicredit
BIT
MB
Mediobanca Banca di Cred...
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
CPR
Davide Campari
BIT
BAMI
Banco BPM
BIT
MONC
Moncler
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
IVG
Iveco Group NV
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network